Skip to Main Content

Author Details

Erin E Longbrake
Yale University
2005
61
19
Wade Schulz (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
38088067A multicenter pilot study evaluating simplified central vein assessment for the diagnosis of multiple sclerosis.Mult Scler2024
35975888Effect of GBCA Use on Detection and Diagnostic Performance of the Central Vein Sign: Evaluation Using a 3-T FLAIR* Sequence in Patients With Suspected Multiple Sclerosis.AJR Am J Roentgenol2023
37480738Influence of menstrual cycle and hormonal contraceptive use on MS symptom fluctuations: A pilot study.Mult Scler Relat Disord2023
37783194Secondary hypogammaglobulinemia in patients with multiple sclerosis on anti-CD20 therapy: Pathogenesis, risk of infection, and disease management.Mult Scler Relat Disord2023
37606046Prior cycles of anti-CD20 antibodies affect antibody responses after repeated SARS-CoV-2 mRNA vaccination.JCI Insight2023
37873265Gut Microbiome Wellness Index 2 for Enhanced Health Status Prediction from Gut Microbiome Taxonomic Profiles.bioRxiv2023
37675826Anti-CD20 monoclonal antibody therapy in postpartum women with neurological conditions.Ann Clin Transl Neurol2023
37312418Microfluidic Immuno-Serolomic Assay Reveals Systems Level Association with COVID-19 Pathology and Vaccine Protection.Small Methods2023
36976460Time for the Next Step in Clinical Trial Evolution?Ann Neurol2023
37468283Early Treatment for Multiple Sclerosis: Time Is Brain.Neurology2023
37097758MOGAD patient autoantibodies induce complement, phagocytosis, and cellular cytotoxicity.JCI Insight2023
36720639Future of Neurology & Technology: Neuroimaging Made Accessible Using Low-Field, Portable MRI.Neurology2023
36634138Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity.Proc Natl Acad Sci U S A2023
34923427Vaccination Against SARS-CoV-2 in Neuroinflammatory Disease: Early Safety/Tolerability Data.Mult Scler Relat Disord2022
36544307Infection risk in a real-world cohort of patients treated with long-term B-cell depletion for autoimmune neurologic disease.Mult Scler Relat Disord2022
36250467Impaired TIGIT expression on B cells drives circulating follicular helper T cell expansion in multiple sclerosis.J Clin Invest2022
36041861Toward Precision Phenotyping of Multiple Sclerosis.Neurol Neuroimmunol Neuroinflamm2022
36203554Impact of the COVID-19 Pandemic on Personal Networks and Neurological Outcomes of People with Multiple Sclerosis: A Case-Control Cross-sectional and Longitudinal Analysis.medRxiv2022
36031693The CELLO trial: Protocol of a planned phase 4 study to assess the efficacy of Ocrelizumab in patients with radiologically isolated syndrome.Mult Scler Relat Disord2022
35959404The White Matter Rounds experience: The importance of a multidisciplinary network to accelerate the diagnostic process for adult patients with rare white matter disorders.Front Neurol2022
36093346Microfluidic immuno-serology assay revealed a limited diversity of protection against COVID-19 in patients with altered immunity.bioRxiv2022
36350491High-Efficacy Therapies for Treatment-Naïve Individuals with Relapsing-Remitting Multiple Sclerosis.CNS Drugs2022
36283322Impact of resilience, social support, and personality traits in patients with neuroinflammatory diseases during the COVID-19 pandemic.Mult Scler Relat Disord2022
35016114Worsening physical functioning in patients with neuroinflammatory disease during the COVID-19 pandemic.Mult Scler Relat Disord2022
35276450Seroconversion after COVID-19 vaccination for multiple sclerosis patients on high efficacy disease modifying medications.Mult Scler Relat Disord2022
32716690Dimethyl fumarate treatment shifts the immune environment toward an anti-inflammatory cell profile while maintaining protective humoral immunity.Mult Scler2021
33515779Influence of immunomodulatory drugs on the gut microbiota.Transl Res2021
33647592MOG-associated encephalitis following SARS-COV-2 infection.Mult Scler Relat Disord2021
33616290Manifestations and impact of the COVID-19 pandemic in neuroinflammatory diseases.Ann Clin Transl Neurol2021
34376559<sup>23</sup>Na imaging: Worth its salt for understanding multiple sclerosis.Proc Natl Acad Sci U S A2021
34484946Neuroinflammation Associated With Tumor Necrosis Factor-α Inhibitor Exposure.Neurol Clin Pract2021
34484933Consensus Curriculum for Fellowship Training in Multiple Sclerosis and Neuroimmunology.Neurol Clin Pract2021
34592690Central vein sign: A diagnostic biomarker in multiple sclerosis (CAVS-MS) study protocol for a prospective multicenter trial.Neuroimage Clin2021
34341094A New England COVID-19 Registry of Patients With CNS Demyelinating Disease: A Pilot Analysis.Neurol Neuroimmunol Neuroinflamm2021
32585616Outcomes and future directions for neuroimmunology/multiple sclerosis fellowship training: Survey of recent trainees.Mult Scler Relat Disord2020
32107321Education Research: Multiple sclerosis and neuroimmunology fellowship training status in the United States.Neurology2020
32655689Sex effects across the lifespan in women with multiple sclerosis.Ther Adv Neurol Disord2020
32593886Therapeutic considerations in a case of progressive encephalomyelitis with rigidity and myoclonus.J Neurol Sci2020
32743517CXCR3+ T cells in multiple sclerosis correlate with reduced diversity of the gut microbiome.J Transl Autoimmun2019
31951523Siponimod Chips Away at Progressive MS.Cell2019
28766993Streamlined EDSS for use in multiple sclerosis clinical practice: Development and cross-sectional comparison to EDSS.Mult Scler2018
28480794Dimethyl fumarate induces changes in B- and T-lymphocyte function independent of the effects on absolute lymphocyte count.Mult Scler2018
29708225Effectiveness of alternative dose fingolimod for multiple sclerosis.Neurol Clin Pract2018
27110589An older dog with newer tricks: Predicting efficacy of IFN-β treatment for multiple sclerosis.Neurol Neuroimmunol Neuroinflamm2016
28280599Efficacy and tolerability of oral versus injectable disease-modifying therapies for multiple sclerosis in clinical practice.Mult Scler J Exp Transl Clin2016
26459150Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients.Mult Scler2016
27581217The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study.Neurology2016
27919490Quantitative visual tests after poorly recovered optic neuritis due to multiple sclerosis.Mult Scler Relat Disord2016
27244583Linking Genotype to Clinical Phenotype in Multiple Sclerosis: In Search of the Holy Grail.JAMA Neurol2016
26720195Effect of Multiple Sclerosis Disease-Modifying Therapies on B Cells and Humoral Immunity.JAMA Neurol2016
  • 1 - 50 of 61

Recommended Authors

Kelsey C Zorn
Weill Institute for Neurosciences, University of California san francisco
Career Start Year 2016
Number of shared co-authors 0
Kathryn C Fitzgerald
Johns Hopkins University School of Medicine
Career Start Year 2012
Number of shared co-authors 5
Amanda L Piquet
University of Colorado School of Medicine
Career Start Year 2012
Number of shared co-authors 0
Benjamin Knier
Technical University of Munich
Career Start Year 2011
Number of shared co-authors 1
Elena H Martinez-Lapiscina
Fundacio Recerca Clinic Barcelona -IDIBAPS
Career Start Year 2010
Number of shared co-authors 1
Joachim Havla
Institute of Clinical Neuroimmunology, LMU Hospital, Ludwig Maximilians University
Career Start Year 2009
Number of shared co-authors 1
James N Brenton
University of Virginia Medical Center
Career Start Year 2008
Number of shared co-authors 1
Mark P Gorman
Boston Children's Hospital, Harvard Medical School
Career Start Year 2007
Number of shared co-authors 4
John R Mills
Mayo Clinic
Career Start Year 2007
Number of shared co-authors 0
Hugh Kearney
St. Vincent's University Hospital
Career Start Year 2007
Number of shared co-authors 0
Kristina M Harris
University of California san francisco
Career Start Year 2006
Number of shared co-authors 1
Zachary S Wallace
Massachusetts General Hospital, and Harvard Medical School.
Career Start Year 2005
Number of shared co-authors 0
Gregory Constantine
University of Pittsburgh
Career Start Year 2004
Number of shared co-authors 0
Athina Papadopoulou
University Hospital Basel
Career Start Year 2003
Number of shared co-authors 2
Michael R Wilson
Weill Institute for Neurosciences, University of California-San Francisco
Career Start Year 2001
Number of shared co-authors 7
Stephen W Reddel
Concord Repatriation General Hospital
Career Start Year 1998
Number of shared co-authors 1
Sergio E Baranzini
University of California san francisco
Career Start Year 1997
Number of shared co-authors 5
Bernhard Hemmer
Technical University of Munich
Career Start Year 1995
Number of shared co-authors 9
Pablo Villoslada
Hospital Clinic of Barcelona-Institut d'Investigacions
Career Start Year 1994
Number of shared co-authors 6
Thomas Korn
TUM School of Medicine, Technical University of Munich
Career Start Year 1993
Number of shared co-authors 3
Diego Cadavid
University of Massachusetts Medical School
Career Start Year 1993
Number of shared co-authors 1
Yuko Shimizu
Tokyo Women's Medical University School of Medicine
Career Start Year 1992
Number of shared co-authors 0
Murali Ramanathan
Department of Pharmaceutical Sciences, State University of New York
Career Start Year 1991
Number of shared co-authors 2
Qi Wu
University of Michigan Medical School
Career Start Year 1989
Number of shared co-authors 0
Teresa C Frohman
Stanford University School of Medicine
Career Start Year 1988
Number of shared co-authors 4
James D Bowen
Swedish Neuroscience Institute
Career Start Year 1987
Number of shared co-authors 5
David Leppert
Biomedicine and Clinical Research, University Hospital Basel, University of Basel
Career Start Year 1985
Number of shared co-authors 3
Scott S Zamvil
Weill Institute for Neurosciences, University of California san francisco
Career Start Year 1980
Number of shared co-authors 7
Elliot M Frohman
Stanford University School of Medicine
Career Start Year 1977
Number of shared co-authors 6
Friedemann Paul
Max-Delbruck Center for Molecular Medicine in the Helmholtz Association
Career Start Year 1977
Number of shared co-authors 6

Collaborators

Anne H Cross
Co-authored papers 12
David A Hafler
Yale School of Medicine, Yale School of Public Health
Co-authored papers 10
Philip L De Jager
Columbia University Medical Center
Co-authored papers 6
Zongqi Xia
University of Pittsburgh
Co-authored papers 5
Michael K Racke
The Ohio State University Wexner Medical Center
Co-authored papers 4
Hiromitsu Asashima
Institute of Medicine, University of Tsukuba
Co-authored papers 4
Peter A Calabresi
Johns Hopkins University School of Medicine
Co-authored papers 3
Tara S Givens
Co-authored papers 3
JoDell E Wilson
Co-authored papers 3
Mary M Tomayko
Yale University School of Medicine
Co-authored papers 3
Jennifer VanOudenhove
Yale Cancer Center and Smilow Cancer Hospital, Yale University School of Medicine
Co-authored papers 2
Russell T Shinohara
University of Pennsylvania
Co-authored papers 2
Stephanie Halene
Smilow Cancer Center, Yale University School of Medicine
Co-authored papers 2
Gary Cutter
University of Alabama at Birmingham
Co-authored papers 2
Shalin Kothari
Yale University
Co-authored papers 2
Lohith Gowda
Yale Cancer Center and Yale School of Medicine
Co-authored papers 2
Giulia Biancon
Yale School of Medicine
Co-authored papers 2
Wade Schulz (CM4AI)
Yale University
Co-authored papers 2
Laura Piccio
Co-authored papers 2
Jennifer M Kwan
Yale School of Medicine
Co-authored papers 2
Nathan D Grubaugh
Yale School of Public Health
Co-authored papers 1
Bruce A C Cree
Co-authored papers 1
Nikhil Lele
Yale University
Co-authored papers 1
Chantal B F Vogels
Yale School of Public Health
Co-authored papers 1
Zhiliang Bai
Yale University
Co-authored papers 1
Wendy S Vargas
Columbia University Medical Center
Co-authored papers 1
Zhiliang Bai
Yale University
Co-authored papers 1
Nils H Petersen
Yale University
Co-authored papers 1
Fredrik Piehl
Co-authored papers 1
Beau M Ances
Washington University School of Medicine
Co-authored papers 1
Release 1.2